KM11060 is primarily utilized in the field of pharmaceutical research and development, particularly in the study of cancer therapies. It functions as a potent inhibitor targeting specific enzymes or proteins involved in tumor growth and proliferation. Researchers employ KM11060 to investigate its efficacy in disrupting signaling pathways that are crucial for cancer cell survival, making it a valuable tool in preclinical studies. Its application extends to the exploration of combination therapies, where it is tested alongside other anticancer agents to enhance treatment outcomes. Additionally, KM11060 is used in biochemical assays to better understand the molecular mechanisms underlying cancer progression, aiding in the identification of novel therapeutic targets.